글로벌 게놈 테스트 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 게놈 테스트 시장

게놈 검사 시장은 2021년에서 2028년까지의 예측 기간 동안 10.27%의 시장 성장을 목격할 것으로 예상됩니다. 게놈 검사 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 의료 분야의 급속한 발전은 게놈 검사 시장의 성장을 가속화하고 있습니다.

유전체학 검사는 유전자 식별을 사용하는 것을 말하며, 유기체의 전체 유전체를 모니터링하는 검사가 포함된 진단 모드로 정의될 수 있습니다. 이 방법은 인간의 유전자 전반에 걸쳐 치명적이거나 해로운 것으로 입증되는 모든 수정이나 변화를 식별하는 데 널리 채택됩니다.

전 세계적으로 유전체학의 적용 분야가 늘어나는 것은 유전체 검사 시장 성장을 견인하는 주요 요인 중 하나입니다. 암 발병률의 증가와 암 연구에서 차세대 시퀀싱의 적용 증가, 유전체 및 유전자 검사 기술과 관련된 혁신과 발전은 시장 성장을 가속화합니다. 유전체학 프로젝트를 지원하기 위한 정부 자금의 급증과 이러한 질병의 조기 발견 채택의 증가는 중증도를 낮추고 증상의 발병을 예방하는 데 도움이 되어 환자 관리에 효과적임이 입증되면서 시장에 더 큰 영향을 미칩니다. 또한, 급속한 도시화, 기술 발전, 연구 개발을 촉진하기 위한 정부 지원, 높은 의료 지출은 유전체 검사 시장에 긍정적인 영향을 미칩니다. 더욱이, 검사의 발전은 2021년에서 2028년의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

On the other hand, lack of approved and accurate scientifically proven test products commercialized is expected to obstruct the market growth. Lack of guidelines and standardizations present currently for the development and utilization is projected to challenge the genomic tests market in the forecast period of 2021-2028.

This genomic tests market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on genomic tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Genomic Tests Market Scope and Market Size

The genomic tests market is segmented on the basis of type, technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of type, the genomic tests market is segmented into predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others.
• On the basis of technology, the genomic tests market is segmented into cytogenetic testing, biochemical testing and molecular testing.
• On the basis of application, the genomic tests market is segmented into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis and others.
• On the basis of end user, the genomic tests market is segmented into hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies and other end users.

Genomic Tests Market Country Level Analysis

The genomic tests market is analyzed and market size insights and trends are provided by country, type, technology, application and end user as referenced above.      

The countries covered in the genomic tests market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genomic tests market because of the presence of majority of key players and government initiatives for promoting precision medicine within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the increase in affordability, and surge in healthcare expenditure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The genomic tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genomic tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genomic tests market. The data is available for historic period 2010-2019.

Competitive Landscape and Genomic Tests Market Share Analysis

The genomic tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genomic tests market.

게놈 검사 시장 보고서에서 다루는 주요 업체는 Ancestry, 23andMe, Inc., Co-Pay Relief Program, Melbourne Genomics Health Alliance, ViaCord, Genova Diagnostics (GDX), Fulgent Genetics, Loxo Oncology, Color, Genomic Health, Royal Brompton & Harefield NHS Foundation Trust, VikingGenetics, Helix OpCo LLC, American Jersey Cattle Association and National All-Jersey Inc., Agendia, FOUNDATION MEDICINE, INC., Memorial Sloan Kettering Cancer Center 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-48061